Shailesh (Shalas) Chitnis
Global business writer and correspondent for The Economist who reports on pharmaceutical markets and corporate strategy, here discussing competition between Novo Nordisk and Eli Lilly.
Best podcasts with Shailesh (Shalas) Chitnis
Ranked by the Snipd community
59 snips
Dec 18, 2025 • 21min
Weight boss? Competition for Novo Nordisk
Shailesh Chitnis, a global business writer, explains how Eli Lilly's ZepBound is shaking up Novo Nordisk's dominance in the slimming drug market. He discusses Novo's missteps in demand forecasting and strategic restructuring. Jonathan Green, a slang expert, argues that early human speech may have included colorful expletives like 'arse,' highlighting the historical significance of slang in culture. Bella King shares insights on the British wool industry's recent price hikes and happier sheep, driven by changing demand and improved conditions.
